| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | glutamine N-acyltransferase activity | 2.74e-05 | 2 | 105 | 2 | GO:0047946 | |
| Pubmed | A dual-activity topoisomerase complex regulates mRNA translation and turnover. | NPC1 DOC2A USP34 STK36 SEMA4B EPPK1 EDC4 KDM6B SYNE3 TRAPPC12 NAV2 NLE1 SLC7A5 TLN2 PCNX1 AKAP13 BCAM ARAP1 | 7.65e-09 | 1105 | 107 | 18 | 35748872 |
| Pubmed | 6.51e-06 | 225 | 107 | 7 | 12168954 | ||
| Pubmed | 9.38e-06 | 2 | 107 | 2 | 11718899 | ||
| Pubmed | 9.38e-06 | 2 | 107 | 2 | 8922396 | ||
| Pubmed | 9.38e-06 | 2 | 107 | 2 | 20700038 | ||
| Pubmed | Mammalian TRAPPIII Complex positively modulates the recruitment of Sec13/31 onto COPII vesicles. | 9.38e-06 | 2 | 107 | 2 | 28240221 | |
| Pubmed | A role for Rab23 in the trafficking of Kif17 to the primary cilium. | 2.81e-05 | 3 | 107 | 2 | 26136363 | |
| Pubmed | 3.90e-05 | 529 | 107 | 9 | 14621295 | ||
| Pubmed | 4.96e-05 | 65 | 107 | 4 | 26655900 | ||
| Pubmed | 5.60e-05 | 4 | 107 | 2 | 8625413 | ||
| Pubmed | 5.60e-05 | 4 | 107 | 2 | 25892053 | ||
| Pubmed | Migratory pathway of sympathetic preganglionic neurons in normal and reeler mutant mice. | 5.60e-05 | 4 | 107 | 2 | 12687699 | |
| Pubmed | 5.60e-05 | 4 | 107 | 2 | 11043403 | ||
| Pubmed | Characterization of the Extracellular Matrix of Normal and Diseased Tissues Using Proteomics. | 6.33e-05 | 135 | 107 | 5 | 28675934 | |
| Pubmed | Rack1 is essential for corticogenesis by preventing p21-dependent senescence in neural stem cells. | 6.99e-05 | 26 | 107 | 3 | 34469723 | |
| Pubmed | Nuclear-encoded mitochondrial ribosomal proteins are required to initiate gastrulation. | 8.77e-05 | 28 | 107 | 3 | 32376682 | |
| Pubmed | Expression of Epiplakin1 in the developing and adult mouse retina. | 9.32e-05 | 5 | 107 | 2 | 20151282 | |
| Pubmed | Y+ and y+ L arginine transporters in neuronal cells expressing tyrosine hydroxylase. | 9.32e-05 | 5 | 107 | 2 | 16085056 | |
| Pubmed | 1.14e-04 | 153 | 107 | 5 | 25037231 | ||
| Pubmed | 1.34e-04 | 486 | 107 | 8 | 20936779 | ||
| Pubmed | New loci associated with central cornea thickness include COL5A1, AKAP13 and AVGR8. | 1.40e-04 | 6 | 107 | 2 | 20719862 | |
| Pubmed | Progression-free survival in ovarian cancer is reflected in epigenetic DNA methylation profiles. | 1.40e-04 | 6 | 107 | 2 | 21577013 | |
| Pubmed | 1.72e-04 | 167 | 107 | 5 | 22159717 | ||
| Pubmed | Quantifying domain-ligand affinities and specificities by high-throughput holdup assay. | 1.88e-04 | 36 | 107 | 3 | 26053890 | |
| Pubmed | ANO1/TMEM16A regulates process maturation in radial glial cells in the developing brain. | 1.95e-04 | 7 | 107 | 2 | 31147466 | |
| Pubmed | 1.95e-04 | 7 | 107 | 2 | 17452640 | ||
| Pubmed | 1.95e-04 | 7 | 107 | 2 | 21062867 | ||
| Pubmed | 1.95e-04 | 7 | 107 | 2 | 23359715 | ||
| Pubmed | 1.95e-04 | 7 | 107 | 2 | 7477295 | ||
| Pubmed | GPR56 functions together with α3β1 integrin in regulating cerebral cortical development. | 1.95e-04 | 7 | 107 | 2 | 23874761 | |
| Pubmed | Emilin1 deficiency causes structural and functional defects of lymphatic vasculature. | 1.95e-04 | 7 | 107 | 2 | 18411305 | |
| Pubmed | 1.95e-04 | 7 | 107 | 2 | 12009310 | ||
| Pubmed | 2.50e-04 | 283 | 107 | 6 | 21903422 | ||
| Pubmed | Blocking nuclear import of pre-integration complex: an emerging anti-HIV-1 drug discovery paradigm. | 2.59e-04 | 8 | 107 | 2 | 20015032 | |
| Pubmed | 2.75e-04 | 101 | 107 | 4 | 9872452 | ||
| Pubmed | The UAS thioredoxin-like domain of UBXN7 regulates E3 ubiquitin ligase activity of RNF111/Arkadia. | 2.85e-04 | 102 | 107 | 4 | 37024974 | |
| Pubmed | 3.33e-04 | 9 | 107 | 2 | 10525473 | ||
| Pubmed | 3.33e-04 | 9 | 107 | 2 | 29360985 | ||
| Pubmed | 3.33e-04 | 9 | 107 | 2 | 11389849 | ||
| Pubmed | A key role for Pak4 in proliferation and differentiation of neural progenitor cells. | 3.33e-04 | 9 | 107 | 2 | 21382368 | |
| Pubmed | 3.33e-04 | 9 | 107 | 2 | 12798291 | ||
| Pubmed | Viral protein R regulates nuclear import of the HIV-1 pre-integration complex. | 3.33e-04 | 9 | 107 | 2 | 9463369 | |
| Pubmed | 3.33e-04 | 9 | 107 | 2 | 24720729 | ||
| Pubmed | 3.33e-04 | 9 | 107 | 2 | 21326825 | ||
| Pubmed | 3.33e-04 | 9 | 107 | 2 | 12414950 | ||
| Pubmed | 3.33e-04 | 9 | 107 | 2 | 11035935 | ||
| Pubmed | 3.33e-04 | 9 | 107 | 2 | 9275210 | ||
| Pubmed | 3.33e-04 | 9 | 107 | 2 | 10366569 | ||
| Pubmed | 3.33e-04 | 9 | 107 | 2 | 10888652 | ||
| Pubmed | 3.33e-04 | 9 | 107 | 2 | 9366553 | ||
| Pubmed | Active nuclear import of human immunodeficiency virus type 1 preintegration complexes. | 3.33e-04 | 9 | 107 | 2 | 1631159 | |
| Pubmed | Genetic modifiers of muscular dystrophy: implications for therapy. | 3.33e-04 | 9 | 107 | 2 | 16916601 | |
| Pubmed | 3.33e-04 | 9 | 107 | 2 | 10860744 | ||
| Pubmed | 3.33e-04 | 9 | 107 | 2 | 8105392 | ||
| Pubmed | Characterization of the nuclear import pathway for HIV-1 integrase. | 3.33e-04 | 9 | 107 | 2 | 11278458 | |
| Pubmed | 3.33e-04 | 9 | 107 | 2 | 12368302 | ||
| Pubmed | Identification of Zika Virus and Dengue Virus Dependency Factors using Functional Genomics. | 3.39e-04 | 422 | 107 | 7 | 27342126 | |
| Pubmed | Biological insights from 108 schizophrenia-associated genetic loci. | 3.60e-04 | 303 | 107 | 6 | 25056061 | |
| Pubmed | 3.82e-04 | 568 | 107 | 8 | 37774976 | ||
| Pubmed | 4.15e-04 | 10 | 107 | 2 | 21528130 | ||
| Pubmed | The crucial role of the TRPM7 kinase domain in the early stage of amelogenesis. | 4.15e-04 | 10 | 107 | 2 | 29273814 | |
| Pubmed | 4.15e-04 | 10 | 107 | 2 | 33790322 | ||
| Pubmed | The lysolipid transporter Mfsd2a regulates lipogenesis in the developing brain. | 4.15e-04 | 10 | 107 | 2 | 30074985 | |
| Pubmed | 4.15e-04 | 10 | 107 | 2 | 21768377 | ||
| Pubmed | The extracellular matrix gene Frem1 is essential for the normal adhesion of the embryonic epidermis. | 4.15e-04 | 10 | 107 | 2 | 15345741 | |
| Pubmed | Angiogenic sprouting into neural tissue requires Gpr124, an orphan G protein-coupled receptor. | 4.15e-04 | 10 | 107 | 2 | 21282641 | |
| Pubmed | Spatiotemporal expression pattern of keratins in skin of AP-2alpha-deficient mice. | 4.15e-04 | 10 | 107 | 2 | 10571739 | |
| Pubmed | 4.16e-04 | 47 | 107 | 3 | 15537664 | ||
| Pubmed | Mouse screen reveals multiple new genes underlying mouse and human hearing loss. | TRPC4AP GRB7 RIPK4 DHX33 EDC4 INTS2 SYNJ2 ARID2 EPC1 DLG2 ZSCAN2 VPS51 | 4.46e-04 | 1242 | 107 | 12 | 30973865 |
| Pubmed | 4.47e-04 | 733 | 107 | 9 | 34672954 | ||
| Pubmed | Polymorphisms in innate immunity genes and risk of childhood leukemia. | 4.52e-04 | 206 | 107 | 5 | 20438785 | |
| Pubmed | Risk of meningioma and common variation in genes related to innate immunity. | 4.63e-04 | 207 | 107 | 5 | 20406964 | |
| Pubmed | Voltage-dependent conformational changes of Kv1.3 channels activate cell proliferation. | 4.73e-04 | 208 | 107 | 5 | 33230847 | |
| Pubmed | Common variation in genes related to innate immunity and risk of adult glioma. | 4.73e-04 | 208 | 107 | 5 | 19423540 | |
| Pubmed | 4.99e-04 | 50 | 107 | 3 | 23658023 | ||
| Pubmed | Extracellular matrix protein composition dynamically changes during murine forelimb development. | 5.06e-04 | 11 | 107 | 2 | 38303699 | |
| Pubmed | Gli3 is required for maintenance and fate specification of cortical progenitors. | 5.06e-04 | 11 | 107 | 2 | 21525285 | |
| Pubmed | 5.06e-04 | 11 | 107 | 2 | 21491429 | ||
| Pubmed | 5.06e-04 | 11 | 107 | 2 | 22509482 | ||
| Pubmed | 5.06e-04 | 11 | 107 | 2 | 37085665 | ||
| Pubmed | 5.06e-04 | 11 | 107 | 2 | 22726441 | ||
| Pubmed | HIV-1 nuclear import: matrix protein is back on center stage, this time together with Vpr. | 5.06e-04 | 11 | 107 | 2 | 9562972 | |
| Pubmed | Regulation of radial glial survival by signals from the meninges. | 5.06e-04 | 11 | 107 | 2 | 19535581 | |
| Pubmed | 5.06e-04 | 11 | 107 | 2 | 27909010 | ||
| Pubmed | 5.06e-04 | 11 | 107 | 2 | 27760310 | ||
| Pubmed | 5.06e-04 | 11 | 107 | 2 | 32245946 | ||
| Pubmed | 5.47e-04 | 754 | 107 | 9 | 35906200 | ||
| Pubmed | NPC1 USP34 SESTD1 CACHD1 RIPK4 KDM6B SBNO1 DLG2 TLN2 PBX1 CUX1 ECE2 | 6.02e-04 | 1285 | 107 | 12 | 35914814 | |
| Pubmed | CAMSAP1 breaks the homeostatic microtubule network to instruct neuronal polarity. | 6.07e-04 | 12 | 107 | 2 | 32839317 | |
| Pubmed | 6.07e-04 | 12 | 107 | 2 | 32780108 | ||
| Pubmed | Abnormal development of the cerebral cortex and cerebellum in the setting of lamin B2 deficiency. | 6.07e-04 | 12 | 107 | 2 | 20145110 | |
| Pubmed | A role for mDia, a Rho-regulated actin nucleator, in tangential migration of interneuron precursors. | 6.07e-04 | 12 | 107 | 2 | 22246438 | |
| Pubmed | 6.07e-04 | 12 | 107 | 2 | 21452199 | ||
| Pubmed | 6.07e-04 | 12 | 107 | 2 | 22228756 | ||
| Pubmed | 6.07e-04 | 12 | 107 | 2 | 29294103 | ||
| Pubmed | 6.07e-04 | 12 | 107 | 2 | 32291340 | ||
| Pubmed | 6.07e-04 | 12 | 107 | 2 | 20181597 | ||
| Pubmed | Mitotic spindle regulation by Nde1 controls cerebral cortical size. | 6.07e-04 | 12 | 107 | 2 | 15473967 | |
| Pubmed | Dynamic expression of the TRPM subgroup of ion channels in developing mouse sensory neurons. | 6.07e-04 | 12 | 107 | 2 | 19850157 | |
| Pubmed | Pocket proteins pRb and p107 are required for cortical lamination independent of apoptosis. | 6.07e-04 | 12 | 107 | 2 | 24056077 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr16q22 | 9.16e-04 | 183 | 107 | 4 | chr16q22 | |
| Cytoband | 16q22.1 | 2.22e-03 | 110 | 107 | 3 | 16q22.1 | |
| ToppCell | IPF-Epithelial-Basal|IPF / Disease state, Lineage and Cell class | 3.91e-07 | 190 | 107 | 7 | ea19e9ce954f2dfde97388db9695325cd92ab88f | |
| ToppCell | IPF-Epithelial-Basal|World / Disease state, Lineage and Cell class | 4.20e-07 | 192 | 107 | 7 | 9b91e0b162e6f3ce86dd15cc33c2e745d069581f | |
| ToppCell | 10x_3'_v2v3-Neoplastic-Differentiated-like-MES-like-MES-like_hypoxia_independent-F|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 4.83e-07 | 196 | 107 | 7 | b8b9801181d7604871b48aebacb295d0a57a5eaf | |
| ToppCell | COVID-19-lung-Fibroblast|lung / Disease (COVID-19 only), tissue and cell type | 5.17e-07 | 198 | 107 | 7 | df3de77216f5c5d6141ec44d01c56b942f611838 | |
| ToppCell | LPS_only-Epithelial_alveolar-AT_1-Differentiating_AT1|LPS_only / Treatment groups by lineage, cell group, cell type | 5.53e-07 | 200 | 107 | 7 | 2dadf317a42a7e27cc1fac74f91b806c93a57108 | |
| ToppCell | Myeloid-Myeloid-E_(Neutrophils)|Myeloid / shred on cell class and cell subclass (v4) | 1.70e-06 | 150 | 107 | 6 | 1bffb8d86b737ac43be902d9468041aef3542f1f | |
| ToppCell | facs-Lung-EPCAM-3m-Epithelial-Alveolar_Epithelial_Type_1|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.72e-06 | 179 | 107 | 6 | 88dbec952507d84b85b08165eec80df99ed1e736 | |
| ToppCell | facs-Lung-EPCAM-3m-Epithelial-type_I_pneumocyte|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.72e-06 | 179 | 107 | 6 | daf8189a22786171e2b629261cf720736aa4ebdb | |
| ToppCell | Epithelial-basal_cell|World / Lineage, Cell type, age group and donor | 4.72e-06 | 179 | 107 | 6 | d9be6647ec7b22747dc00dce4ea307b6af412dfa | |
| ToppCell | COPD-Epithelial-Basal|COPD / Disease state, Lineage and Cell class | 5.36e-06 | 183 | 107 | 6 | 0f760e393edc91009bf6c7e02eeac039a1dfb4ed | |
| ToppCell | 5'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_2-Peribronchial_fibroblasts-Peribronchial_fibroblasts_L.2.1.3.1|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 5.71e-06 | 185 | 107 | 6 | 87c416d14ca6255bee39b16e7571553e36ee3069 | |
| ToppCell | E17.5-Mesenchymal-mesenchymal_fibroblast-mesenchymal_alveolar_niche_cell|E17.5 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 5.71e-06 | 185 | 107 | 6 | c85bba1210f1d389add3e40be9b96abac40cf8c1 | |
| ToppCell | Control-Myeloid-MoAM3,_VCAN|Myeloid / Condition, Lineage and Cell class | 5.89e-06 | 186 | 107 | 6 | 0bf16ac48931b62bb3c33d63ff4279654148e293 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial-Distal_tubule_epithelial_cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 6.07e-06 | 187 | 107 | 6 | 77886f99c229610abd28c4c370d2c7d1536c9782 | |
| ToppCell | COVID-19-Epithelial_cells-Airway_basal|COVID-19 / group, cell type (main and fine annotations) | 6.07e-06 | 187 | 107 | 6 | 8407a82e98f56a94ea26562bcb6bbe00a8f41661 | |
| ToppCell | E15.5-Mesenchymal-mesenchymal_fibroblast-mesenchymal_alveolar_niche_cell|E15.5 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 6.85e-06 | 191 | 107 | 6 | 053b3664f509baa107feaf90730f80ebf9ac8f14 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive|renal_cortex_nuclei / Celltypes from Cells and Nuclei per compartment and clinical group | 7.06e-06 | 192 | 107 | 6 | 8b86db2ebe0199fee0e9800566a619a24bfdeed5 | |
| ToppCell | LPS-antiTNF-Stromal_mesenchymal-Matrix_Fibroblast-Activated_MatrixFB|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 7.49e-06 | 194 | 107 | 6 | 89b706af2b25991fc2707eb24f49ba6ff3ae01f7 | |
| ToppCell | COVID-19-Fibroblasts-Alveolar_FB|COVID-19 / group, cell type (main and fine annotations) | 7.71e-06 | 195 | 107 | 6 | 603050beeb33c331d4b2e3fa46cae3f3e0e4bdc7 | |
| ToppCell | COVID-19-Fibroblasts-Intermediate_pathological_FB|COVID-19 / group, cell type (main and fine annotations) | 8.17e-06 | 197 | 107 | 6 | f1c8936986123a3151140c374fcd62d6705c530b | |
| ToppCell | COPD-Stromal-Myofibroblast|World / Disease state, Lineage and Cell class | 8.17e-06 | 197 | 107 | 6 | d51f484b4e01ac64233950d0b97fa88825ea1dbb | |
| ToppCell | COVID-19-Fibroblasts|COVID-19 / group, cell type (main and fine annotations) | 8.17e-06 | 197 | 107 | 6 | fb847f2277609c31fffcdf49517243ce0684facf | |
| ToppCell | COVID-19-lung-Fibroblast|COVID-19 / Disease (COVID-19 only), tissue and cell type | 8.41e-06 | 198 | 107 | 6 | 3ec01a55ade5e1627258cc3cfebb2c3207a4cb43 | |
| ToppCell | IPF-Endothelial-VE_Peribronchial|Endothelial / Disease state, Lineage and Cell class | 8.41e-06 | 198 | 107 | 6 | b8bd1ba268480f54451648e01631b615a3401144 | |
| ToppCell | 10x5'v1-week_14-16-Mesenchymal_osteo-stroma-osteoblast_precursor|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 8.41e-06 | 198 | 107 | 6 | bc9c9f2c87282b5ef8514773e065d2a6b5dde338 | |
| ToppCell | 10x_3'_v3-blood_(10x_3'_v3)-myeloid-myeloid_granulocytic-neutrophil|blood_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 8.91e-06 | 200 | 107 | 6 | 6beabd5bad042d4d65c89c2f537c7376230f7c08 | |
| ToppCell | 367C-Fibroblasts-Fibroblast-B_(Myofibroblast)-|367C / Donor, Lineage, Cell class and subclass (all cells) | 8.91e-06 | 200 | 107 | 6 | 082e718c1da3f4fdd33a001d15ad3ddb2be985c7 | |
| ToppCell | 367C-Fibroblasts-Fibroblast-B_(Myofibroblast)|367C / Donor, Lineage, Cell class and subclass (all cells) | 8.91e-06 | 200 | 107 | 6 | 731e55070a7ff315091855bd88cda30e5a7e1a98 | |
| ToppCell | 10x_3'_v3-blood_(10x_3'_v3)-myeloid-myeloid_granulocytic|blood_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 8.91e-06 | 200 | 107 | 6 | 026495aa7f1e7528a01d9199475cfc393677fc60 | |
| ToppCell | PBMC-Control-Myeloid-Neutrophil-Neutrophil-Neu_1|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 2.48e-05 | 143 | 107 | 5 | b405dba9a83a99cc7b53ce71772bc52a0bbb0d4e | |
| ToppCell | facs-Marrow-T-cells-24m-Myeloid-granulocyte|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.22e-05 | 151 | 107 | 5 | ced4f7ee377a23a804ae6fde624e8b55b79f1fd8 | |
| ToppCell | facs-Marrow-T-cells-24m-Myeloid-granulocyte|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.22e-05 | 151 | 107 | 5 | b52bb3b88e9a6473f571053537b8beb418678539 | |
| ToppCell | Children_(3_yrs)-Epithelial-basal_cell-D032|Children_(3_yrs) / Lineage, Cell type, age group and donor | 3.87e-05 | 157 | 107 | 5 | 6ee2692f705bdd93ba523dffaf2f0cd921b47e28 | |
| ToppCell | LPS-IL1RA-Stromal_mesenchymal-Fibroblasts-Pericyte_2|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 3.99e-05 | 158 | 107 | 5 | 7f5426585d0d299d2b48e5fcb349950feffdef33 | |
| ToppCell | droplet-Trachea-3m-Hematologic-Erythrocytic-erythrocyte-erythrocyte|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 4.24e-05 | 160 | 107 | 5 | 6eac17f73a19e5cd74e96aa6a5919d8a1106dca2 | |
| ToppCell | droplet-Trachea-nan-3m-Hematologic|Trachea / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.24e-05 | 160 | 107 | 5 | 3ab3c525e1bedc0225fa31d992e43832fa68772a | |
| ToppCell | droplet-Trachea-nan-3m-Hematologic-nan|Trachea / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.24e-05 | 160 | 107 | 5 | 48b1e7ad32984eb74e25695d27d147f2f5ec18d1 | |
| ToppCell | droplet-Trachea-3m-Hematologic-Erythrocytic|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 4.24e-05 | 160 | 107 | 5 | 8840c49e1f9ef3433cb6d0b7a5bf3d80b9def0e3 | |
| ToppCell | droplet-Trachea-3m-Hematologic-Erythrocytic-erythrocyte|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 4.24e-05 | 160 | 107 | 5 | 88ad2478c91e1038903b7be89ba612170636f723 | |
| ToppCell | PBMC-Severe-Myeloid-Neutrophil-Neutrophil-Neu_2|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 4.24e-05 | 160 | 107 | 5 | bb1bb3673059768c0ea0160d29fff127f3a4ecb4 | |
| ToppCell | droplet-Trachea-nan-3m-Hematologic-blood_cell|Trachea / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.24e-05 | 160 | 107 | 5 | 173f46dd8807b06a2184890ac0e0df11fe039827 | |
| ToppCell | PBMC-Severe-Myeloid-Neutrophil-Neutrophil-Neu_2|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 4.24e-05 | 160 | 107 | 5 | 76f49b8b4450fa8acd36326bfa36a5d1f4bd95fb | |
| ToppCell | 390C-Myeloid-Macrophage-SPP1+_Macrophage_2|Myeloid / Donor, Lineage, Cell class and subclass (all cells) | 4.37e-05 | 161 | 107 | 5 | 2fe77af3b41e6eacb707a64feea18f9991618173 | |
| ToppCell | Globus_pallidus-Neuronal-Inhibitory-iN1(Gad1Gad2_Th)-Inhibitory_Neuron.Gad1Gad2.Trh_(Substantia_Innominata_(SI))-|Globus_pallidus / BrainAtlas - Mouse McCarroll V32 | 4.58e-05 | 82 | 107 | 4 | 73349906bcc8d1a40dc03df7a490a963e85564f2 | |
| ToppCell | Globus_pallidus-Neuronal-Inhibitory-iN1(Gad1Gad2_Th)-Inhibitory_Neuron.Gad1Gad2.Trh_(Substantia_Innominata_(SI))--|Globus_pallidus / BrainAtlas - Mouse McCarroll V32 | 4.58e-05 | 82 | 107 | 4 | 15bc417aaace2b1d680904a622fe76e95083c9ff | |
| ToppCell | Globus_pallidus-Neuronal-Inhibitory-iN1(Gad1Gad2_Th)-Inhibitory_Neuron.Gad1Gad2.Trh_(Substantia_Innominata_(SI))|Globus_pallidus / BrainAtlas - Mouse McCarroll V32 | 4.58e-05 | 82 | 107 | 4 | 697e1da3095c8483b8181b290fa5417bdc9cee54 | |
| ToppCell | normal_Lung-Fibroblasts-Myofibroblasts|Fibroblasts / Location, Cell class and cell subclass | 4.77e-05 | 164 | 107 | 5 | 9b4a6007abae992db871d9f6f731d5af724de30d | |
| ToppCell | TCGA-Lung-Primary_Tumor-Lung_Carcinoma-Lung_Squamous_Cell_Carcinoma-4|TCGA-Lung / Sample_Type by Project: Shred V9 | 5.35e-05 | 168 | 107 | 5 | aefea14b8b1c1b6a05f827effd22ba15274fddc9 | |
| ToppCell | Control-NK|Control / Disease group and Cell class | 5.35e-05 | 168 | 107 | 5 | 683d389c8a1e791bfc773e63148115a21a6566db | |
| ToppCell | facs-Marrow-Granulocytes-18m-Myeloid-granulocyte|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.50e-05 | 169 | 107 | 5 | a5964aef04093b460bbe29d5e2e7389f8fd2d46f | |
| ToppCell | E18.5-Mesenchymal-Mesenchymal_structural-Fibroblastic-PMP-PMP_mature|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 5.50e-05 | 169 | 107 | 5 | 7cb1b87be66a22fe5731bb1b55bc515920fe3e8b | |
| ToppCell | facs-Marrow-Granulocytes-18m-Myeloid-granulocyte|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.50e-05 | 169 | 107 | 5 | e0076aa61b4ef3f836f5750005d0469d3982eb6d | |
| ToppCell | droplet-Spleen-SPLEEN-30m-Myeloid-nan|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.50e-05 | 169 | 107 | 5 | 1000eaf5158596b4898bedcc802b31db76b05a48 | |
| ToppCell | droplet-Spleen-SPLEEN-30m-Myeloid|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.50e-05 | 169 | 107 | 5 | 83b854fa8fd9017df8f9207d9ced260eee98e8c1 | |
| ToppCell | Control-Epithelial_cells-Airway_basal|Control / group, cell type (main and fine annotations) | 5.81e-05 | 171 | 107 | 5 | 3965ced4be6db14265a90673502fceee425837ca | |
| ToppCell | droplet-Marrow-nan-3m-Hematologic-proerythroblast|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.98e-05 | 172 | 107 | 5 | cfcfa7eeff1805bedf10a3c07826459914c3e872 | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell_cycling-Cycling_Proximal_Tubule_Epithelial_Cell_low-phase|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 6.14e-05 | 173 | 107 | 5 | 506efcaa5afd6ed5e565c4c4def6a4505fea97c5 | |
| ToppCell | 5'-GW_trimst-1.5-SmallIntestine-Epithelial-neuro-epithelial-K_cells_(GIP+)|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 6.31e-05 | 174 | 107 | 5 | 3503c7dec498597f76a86dbd5e4bb2311e743bde | |
| ToppCell | 3'-Parenchyma_lung-Mesenchymal-Mesenchymal_Myocytic-myocytic_fibroblast-Myofibroblasts-Myofibroblasts_L.2.3.2.2|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 6.49e-05 | 175 | 107 | 5 | 1799a7be623dc3bf53ba580a7c47d2619969d708 | |
| ToppCell | nucseq-Epithelial-Epithelial_Airway-Basal/Suprabasal-Basal|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 6.84e-05 | 177 | 107 | 5 | ce86dfaeb74d995a19aea62f0fb15c4c0bb854b0 | |
| ToppCell | COPD-Epithelial-Basal|Epithelial / Disease state, Lineage and Cell class | 7.03e-05 | 178 | 107 | 5 | 441d1dba720141891b11f404744c59834d80e6c5 | |
| ToppCell | LPS-IL1RA-Epithelial_alveolar-AT_1-Differentiating_AT1|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 7.22e-05 | 179 | 107 | 5 | 04ce3673e46606f63d9c87bcba3a64c96817d812 | |
| ToppCell | 5'-Airway_Nasal-Mesenchymal-Fibroblastic|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 7.41e-05 | 180 | 107 | 5 | 935c091bbcd6d10b81dc4731779e5bd98205c99f | |
| ToppCell | 5'-Airway_Nasal-Mesenchymal|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 7.41e-05 | 180 | 107 | 5 | 3dd384b7f3d9582b8fec9fe05100e466e6218b76 | |
| ToppCell | Control-Classical_Monocyte-cMono_4|Control / Disease condition and Cell class | 7.61e-05 | 181 | 107 | 5 | f3e1d8fe5cf1eba19e51c3680a55306cae687fe9 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD|renal_cortex_nuclei / Celltypes from Cells and Nuclei per compartment and clinical group | 7.61e-05 | 181 | 107 | 5 | c80ffa2ded5975a88e9a1a7d333196f95237bf0a | |
| ToppCell | COPD-Epithelial-Basal|World / Disease state, Lineage and Cell class | 7.61e-05 | 181 | 107 | 5 | 6d8a886b4afe729f8a05b9c0f4ea9375de735da4 | |
| ToppCell | Control-Epithelial-Basal|Control / Disease state, Lineage and Cell class | 7.81e-05 | 182 | 107 | 5 | caddd0a52f0234ea6a916186ffaf2454cdcd80ee | |
| ToppCell | NS-moderate-d_16-33-Lymphoid-NK|d_16-33 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 7.81e-05 | 182 | 107 | 5 | fb503f8ecd013f1f2161a5841572b57cfcddb6fa | |
| ToppCell | 5'-Airway_Nasal-Mesenchymal-Fibroblastic-fibroblastic_type_2|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 8.01e-05 | 183 | 107 | 5 | 803376f5260de83c48d4f7301278d078a32b3e6e | |
| ToppCell | 5'-Airway_Nasal-Mesenchymal-Fibroblastic-fibroblastic_type_2-Peribronchial_fibroblasts-Peribronchial_fibroblasts_L.2.1.3.1|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 8.01e-05 | 183 | 107 | 5 | 6d98973098c6d20c5305bce6a83a549a7d8dbfba | |
| ToppCell | facs-Lung-EPCAM-3m-Epithelial-Basal|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.01e-05 | 183 | 107 | 5 | ecac1cfaff7553a60305b34d6cede6973ffb5430 | |
| ToppCell | 3'-Parenchyma_lung-Epithelial-Airway_epithelium-respiratory_basal_cell-Basal_resting|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 8.01e-05 | 183 | 107 | 5 | ec2af3402b51f11466d2a5783a6b33746b6a7fc9 | |
| ToppCell | 5'-Airway_Nasal-Mesenchymal-Fibroblastic-fibroblastic_type_2-Peribronchial_fibroblasts|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 8.01e-05 | 183 | 107 | 5 | cc7f5a17b40e8d901885174922e5fa8877643071 | |
| ToppCell | LPS-antiTNF-Epithelial_alveolar-AT_1|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 8.01e-05 | 183 | 107 | 5 | ff6dde877659cde9daa3263db0932c9c9ef1adac | |
| ToppCell | facs-Lung-EPCAM-3m-Epithelial-respiratory_basal_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.01e-05 | 183 | 107 | 5 | f6ebfd7f61e912f92bd07313cc213a171747ac03 | |
| ToppCell | IPF-Myeloid-Mast|Myeloid / Disease state, Lineage and Cell class | 8.22e-05 | 184 | 107 | 5 | 7326a16d7d3ae41b8c9d2beaec7f977b374f3469 | |
| ToppCell | normal_Lung-Fibroblasts-Myofibroblasts|normal_Lung / Location, Cell class and cell subclass | 8.22e-05 | 184 | 107 | 5 | 0b336489c10e8c3c957795dd845454f03404382b | |
| ToppCell | IPF-Myeloid-Mast|World / Disease state, Lineage and Cell class | 8.22e-05 | 184 | 107 | 5 | 7aefa182acad5a53c730945fec85329d7168606a | |
| ToppCell | IPF-Myeloid-Mast|IPF / Disease state, Lineage and Cell class | 8.22e-05 | 184 | 107 | 5 | c3baf21f10b45cf91ac99997a59f353bcf3de8b7 | |
| ToppCell | Control-Epithelial_alveolar-AT_2-Differentiating_AT2|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 8.43e-05 | 185 | 107 | 5 | 0d2add28ac1f4fa6de7699be009bf8391badaf4c | |
| ToppCell | COVID-19-Fibroblasts-Adventitial_FB|COVID-19 / group, cell type (main and fine annotations) | 8.43e-05 | 185 | 107 | 5 | a5aebf2b9b05b550d021272731d68af9a6b1229d | |
| ToppCell | 343B-Fibroblasts-Fibroblast-E-|343B / Donor, Lineage, Cell class and subclass (all cells) | 8.65e-05 | 186 | 107 | 5 | 1bac7825c2fe3e6cdff65026b09b9ccaa40fa27f | |
| ToppCell | LPS-IL1RA-Epithelial_alveolar-AT_1-Differentiating_AT2|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 8.65e-05 | 186 | 107 | 5 | 4e94158db52df41d71e67b02b9895a358eebee0f | |
| ToppCell | 343B-Fibroblasts-Fibroblast-E|343B / Donor, Lineage, Cell class and subclass (all cells) | 8.65e-05 | 186 | 107 | 5 | 59db239f1864a5d4f1570c93219dbd7ac5b6db35 | |
| ToppCell | Fetal_29-31_weeks-Epithelial-alveolar_epithelial_cell_type_2-D088|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 8.65e-05 | 186 | 107 | 5 | acfa68a2afb7d2b51c9b469a1965fe5cc5d5e64e | |
| ToppCell | COVID-19-kidney-Fibroblast-1|COVID-19 / Disease (COVID-19 only), tissue and cell type | 8.87e-05 | 187 | 107 | 5 | 76bfe8c42430a230a8bdf299575c444fb7780f24 | |
| ToppCell | Control-Fibroblasts-Alveolar_FB|Control / group, cell type (main and fine annotations) | 8.87e-05 | 187 | 107 | 5 | 92d468dde81125d51daf7abd4703741abe1ab91c | |
| ToppCell | COPD-Epithelial-ATII|Epithelial / Disease state, Lineage and Cell class | 8.87e-05 | 187 | 107 | 5 | 030af361f8bdcd0aff4ec1922702833325cf74d8 | |
| ToppCell | E16.5-samps-Mesenchymal|E16.5-samps / Age Group, Lineage, Cell class and subclass | 9.09e-05 | 188 | 107 | 5 | 3f0f662be684e3a4c6652e636cc135a39a1d2790 | |
| ToppCell | COVID-19-kidney-DCT|kidney / Disease (COVID-19 only), tissue and cell type | 9.09e-05 | 188 | 107 | 5 | df1fd0819d301679f3c9ea404e942e39095912eb | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-airway_smooth_muscle_cell-D062|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 9.09e-05 | 188 | 107 | 5 | c29aaae3c5bb7cd6b9b3defd4d27afde3af19ba0 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-high_collagen-matrisome_fibroblast|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 9.32e-05 | 189 | 107 | 5 | 71397e993a77d70b2eeede240bdfc7660b558987 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-high_collagen-matrisome_fibroblast-|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 9.32e-05 | 189 | 107 | 5 | 4eea4759520c312bd17a681034d8074e47093d2b | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-Degenerative_Fibroblast|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 9.32e-05 | 189 | 107 | 5 | 9e1a51997ef9b6999d9b40cf0a55e561e3b4a84c | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell-Distal_Convoluted_Tubule_Cell_Type_1|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 9.32e-05 | 189 | 107 | 5 | 975c0f079903ae36b0ffa54e86294d42ec7697de | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 9.32e-05 | 189 | 107 | 5 | 7eb8f5a951e80f1cfac4d7c9eb169f4eb100c917 | |
| ToppCell | renal_papilla_nuclei-Hypertensive_with+without-CKD-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell-Adaptive_/_Maladaptive_/_Repairing_Thick_Ascending_Limb_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 9.32e-05 | 189 | 107 | 5 | 8c8ca3b30d9be6c854615459a7bfba82b427c8bc | |
| ToppCell | renal_papilla_nuclei-Hypertensive_with+without-CKD-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 9.32e-05 | 189 | 107 | 5 | 5d902a4660a27548764bf04c6de152b565da835c | |
| ToppCell | IPF-Epithelial-Basal|Epithelial / Disease state, Lineage and Cell class | 9.56e-05 | 190 | 107 | 5 | 4f15842b424eefadbfe451875e517cf70e29607f | |
| Disease | esophageal carcinoma (is_marker_for) | 3.90e-05 | 3 | 107 | 2 | DOID:1107 (is_marker_for) | |
| Disease | hepatocellular carcinoma (is_marker_for) | 1.17e-04 | 301 | 107 | 7 | DOID:684 (is_marker_for) | |
| Disease | carotid artery intima media thickness | 2.40e-04 | 450 | 107 | 8 | EFO_0007117 | |
| Disease | pulse pressure measurement | NPC1 ZNF438 USP34 COL6A3 NBEAL1 DYNC2H1 PCDHA4 KDM6B ITIH1 FCSK TLN2 AKAP13 CCDC157 NIN | 5.09e-04 | 1392 | 107 | 14 | EFO_0005763 |
| Disease | Malignant neoplasm of breast | KPNA5 ZNF438 DYNC2H1 GRB7 ADAM12 RUFY1 CUTC SBNO1 SYNJ2 TRAPPC12 NLE1 CUX1 | 5.25e-04 | 1074 | 107 | 12 | C0006142 |
| Disease | multimerin-2 measurement | 5.75e-04 | 10 | 107 | 2 | EFO_0801809 | |
| Disease | ADHD symptom measurement | 8.40e-04 | 12 | 107 | 2 | EFO_0007860 | |
| Disease | severe acute respiratory syndrome, COVID-19 | 1.24e-03 | 447 | 107 | 7 | EFO_0000694, MONDO_0100096 | |
| Disease | response to cranial radiation therapy, short-term memory | 1.37e-03 | 60 | 107 | 3 | EFO_0004335, EFO_0010950 | |
| Disease | brain age measurement | 2.37e-03 | 20 | 107 | 2 | EFO_0010602 | |
| Disease | intraocular pressure measurement | 2.58e-03 | 509 | 107 | 7 | EFO_0004695 | |
| Disease | activities of daily living score measurement | 2.62e-03 | 21 | 107 | 2 | EFO_0008451 | |
| Disease | white matter microstructure measurement | 3.02e-03 | 390 | 107 | 6 | EFO_0005674 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| GVNGIQLQGTLRVIL | 211 | A0FGR9 | |
| GFRLNIQGLERTLQG | 631 | Q9H2F5 | |
| ILERGQRGVGDVLLQ | 66 | Q9H0I2 | |
| QRGVGDVLLQLEGIS | 71 | Q9H0I2 | |
| GQLGSLQGRAQELLL | 1006 | A6NC98 | |
| QLRDVGGEGVQQGLL | 371 | O76031 | |
| RQREELGQGLQGVEQ | 146 | Q07065 | |
| LGQGLQGVEQKVQSL | 151 | Q07065 | |
| VQERFGRSLLELGGN | 286 | P49419 | |
| DNNLGQRLFGETILG | 1141 | P39880 | |
| VIENDIIGNRGSGLQ | 816 | Q9UK96 | |
| NEVEILQGLVSGNLG | 2426 | Q12802 | |
| LGINDIEGQRVLQIA | 276 | Q68CP9 | |
| GNLLLGIVGVDVNLA | 476 | Q5VU97 | |
| IRQADNQGLTIGILV | 701 | O43184 | |
| QLVLLGGVGARREAQ | 16 | Q5T7M4 | |
| GLSNLVARTEGLDQQ | 501 | O14678 | |
| ALQRGAQDLVDILQG | 146 | P55273 | |
| LQEFGRIDILVNNGG | 126 | Q9Y394 | |
| EAQVQLLVGRLEGAG | 406 | Q569K6 | |
| AAGGLVGLIQLGQEQ | 146 | Q8TE56 | |
| TNLILGEGRGFEISQ | 611 | Q709F0 | |
| ILRLGEQESKQNGIG | 451 | O15131 | |
| QIQIQLLLGFIGRGN | 1571 | Q6ZS30 | |
| ERALAEGQQRGGQLQ | 1006 | Q6P2E9 | |
| GLEIVRGRLQNAGLN | 61 | P25092 | |
| LQAFLEQVNRIGDGL | 886 | Q9Y4B5 | |
| EGGRKQDIGDILQQI | 36 | P40424 | |
| LQLGQRLGGEIVSAD | 41 | Q9H3H1 | |
| GLQILQTGVGQREEA | 546 | Q16849 | |
| GGQELLELLLRVQGG | 131 | Q9Y4H4 | |
| EATNLNGGLLRGIEI | 366 | P19827 | |
| NGGLLRGIEILNQVQ | 371 | P19827 | |
| RVLGNLDLQSEEIQG | 1016 | O15054 | |
| NGERLNGRQTLGENI | 696 | P0DPD6 | |
| EIGNGLVTFQLRGLE | 1601 | Q96RV3 | |
| GEGVTLQRNITLLNG | 41 | Q8MH63 | |
| ATLQQQLGAGEALGL | 76 | P54845 | |
| LQIQGLQESLGEGIR | 101 | Q969I3 | |
| FLIRQAQGLQQELGG | 691 | Q9H0H0 | |
| GRLELQQLQAERGGL | 221 | P48681 | |
| ITLGTELAERQGNGQ | 341 | P22001 | |
| QGLIGSVEEQLAQLR | 376 | P08779 | |
| GEGVTLQRNITLLNG | 41 | Q01650 | |
| LQQIQGLIGGLEAQL | 361 | P19012 | |
| SQRLIGQQGLVDGLF | 441 | Q14451 | |
| GQQGLVDGLFLVRES | 446 | Q14451 | |
| GLIQAGDIILAVNGR | 56 | P29475 | |
| QGETLDQQLGRVLGE | 716 | O15118 | |
| GLGQLTTEGVRQQLE | 66 | Q9BZG2 | |
| RGGLLEVNLQNGILF | 71 | Q9UN74 | |
| QVNSGGVLLRLQVGE | 201 | P02747 | |
| ELQLSEQLLRTFGGG | 811 | Q8N0W3 | |
| DEFIINLIRGLGGNL | 2186 | Q8NCM8 | |
| QVNGERLNGRQTLGE | 766 | P0DPD8 | |
| GEGLQQTLRDLAQAV | 446 | Q5TZA2 | |
| QAEQGQGLLEERGRI | 241 | Q14183 | |
| EGQILQGDRLLQVDG | 991 | Q68DX3 | |
| VNSLDIGNDNIRVGL | 666 | P12111 | |
| QLRNLDNAVLIGETG | 86 | Q9H6R0 | |
| LQIQGFQESLGEGIR | 101 | A0A0U1RQE8 | |
| LLDLNNQSVGIEGGA | 41 | Q9ULC5 | |
| NEQGIQQIGLELGRS | 121 | P20908 | |
| GNSLQILDQVELRAG | 106 | Q99062 | |
| LGRLLGEVQALRGVQ | 136 | Q9ULV5 | |
| GGGITDRNLQRILEG | 201 | Q9NTM9 | |
| LQRGDQILSVNGIDL | 461 | Q15700 | |
| LEQLGGLLANVSGEL | 446 | Q9Y6C2 | |
| ALRTGGQELEQTGLR | 41 | Q9NZY2 | |
| VNLEGNLTLEGVTRG | 316 | P50895 | |
| LLDQVGGLGRFQILQ | 6 | Q6T423 | |
| RQGLIGVGLINVEDR | 1076 | A3KN83 | |
| VLARLQLLEQQVVGG | 741 | Q9P2E2 | |
| LLTQVGAQVLGRLGD | 6 | P09001 | |
| DVRNGGQILIADLRG | 41 | P55735 | |
| RLLVQFQDEGGQLLG | 16 | Q9NVX2 | |
| NILLQLRQGQLTGRG | 36 | Q8TEL6 | |
| AQLSRLQGLQEEGLD | 586 | Q6ZMZ3 | |
| VNLLGSRGGEEVLNR | 301 | O15056 | |
| GDGALSLLQQGEQLL | 1046 | Q8N4C6 | |
| IENEGLNVLVLRLQG | 1316 | Q8N4C6 | |
| KLQQELGGRIGALQL | 521 | Q96T51 | |
| VGLVGRELSEQLGQA | 1306 | P58107 | |
| GINIQGLSAEEIRNG | 161 | Q8IVL1 | |
| GDLLLVGTQQLGEFQ | 641 | Q9NPR2 | |
| TQLVEAARGLGQLGE | 1526 | A1L4H1 | |
| FQGNGLNGELIRQVL | 276 | P57078 | |
| EQILQLGRLLIGLGD | 1526 | Q7RTU9 | |
| LLGQLGQQGVTFDLQ | 806 | Q9NRP7 | |
| LQGLREKGQGLLDQI | 431 | Q86VW0 | |
| LIELFLQLGNGAGNR | 601 | Q96P48 | |
| EILLVFQQGNLGLGS | 496 | Q8IXR9 | |
| LAQEQGGGDNSLLVR | 356 | Q9UID3 | |
| LDLGLNEIGQELTGQ | 436 | O15455 | |
| SQDREVGQLIGLQGT | 201 | Q7Z7L9 | |
| LLLLLQGSADGNGIQ | 11 | Q8WZ59 | |
| RGELLVLDLQGVGEN | 1916 | Q9BX84 | |
| QEEARLTLAGLGTQQ | 436 | Q9NZQ8 | |
| QLLSGIGRISLQIGD | 581 | Q8WVT3 | |
| DGRLIQGDQILSVNG | 1571 | Q8NI35 | |
| VEILGDLLQGRGLQE | 1166 | P35916 | |
| LTIEQGNLGLRINGE | 51 | Q9ULI2 | |
| RQQLQLELLELLGGQ | 51 | I3L0S3 | |
| LLGGQVLQRIQDGVA | 61 | I3L0S3 | |
| EGLGGNIEQLVARSN | 661 | Q92973 | |
| SIGQASGDLLRQIGE | 646 | Q9Y4G6 | |
| AGGLQQLLEIFNSGI | 1491 | Q70CQ2 | |
| LQLLSDVLRGQGEAG | 156 | Q9Y4F4 | |
| LGGLGQDVLLNNSLT | 461 | Q7Z4V0 | |
| VNLIIGLEQDGIIDG | 76 | Q9BZW5 | |
| QLSLVIDGGQIGDGQ | 216 | Q86U90 | |
| QTLGRAQLGLGEIIL | 131 | Q6PID6 | |
| GLATNREAQGGQRLL | 1456 | Q6PIF6 |